Ultragenyx Pharmaceutical (UP0.F) Q3 2024 Earnings

Aug 1Confirmed
Q4 2023
Q1 2024
Q2 2024
Q3 2024
-2.1
-1.87
-1.64
-1.41

Details

Expected EPS
-1.53903426325
Actual EPS
-1.40866
Surprise EPS
0.13
Surprise Percent
+8.47%

Description

⁨Ultragenyx Pharmaceutical⁩ (⁦UP0.F⁩) has reported earnings of ⁦-1.40866⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts